Accueil>>Signaling Pathways>> Obesity, Appetite Control & Diabetes>> Diabetes>>1,2-Diheptanoyl-sn-glycero-3-PC

1,2-Diheptanoyl-sn-glycero-3-PC (Synonyms: DHPC-C7, di-C7-PC)

Catalog No.GC41794

1,2-Diheptanoyl-sn-glycero-3-PC (DHPC-C7) is a synthetic phosphatidylcholine containing the short-chain (7:0) heptanoic acid at the sn-1 and sn-2 positions.

Products are for research use only. Not for human use. We do not sell to patients.

1,2-Diheptanoyl-sn-glycero-3-PC Chemical Structure

Cas No.: 39036-04-9

Taille Prix Stock Qté
100mg
121,00 $US
En stock
250mg
284,00 $US
En stock
500mg
511,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

1,2-Diheptanoyl-sn-glycero-3-PC (DHPC-C7) is a synthetic phosphatidylcholine containing the short-chain (7:0) heptanoic acid at the sn-1 and sn-2 positions. It is commonly used in the formation of lipid bilayers and mixed micelles that has a critical micelle concentration (CMC) of 1.6 mM. Short-chain phospholipids, such as DHPC-C7 and 1,2-dihexanoyl-sn-glycero-PC , increase the formation rate of substrate-supported planar phospholipid bilayers on glass and silica. DHPC-C7 inhibits insulin fibril formation in vitro in a concentration-dependent manner and inhibits cytotoxicity induced by insulin fibril formation in PC12 and SH-SY5Y cells when used at concentrations ranging from 0.5 to 4 mM.

Avis

Review for 1,2-Diheptanoyl-sn-glycero-3-PC

Average Rating: 5 ★★★★★ (Based on Reviews and 1 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1,2-Diheptanoyl-sn-glycero-3-PC

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.